Jefferies boosted its price target on Buy-rated Aegerion Pharmaceuticals (NASDAQ: AEGR) from $50 to $82 following the Jefferies 2013 Global ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE